BPC-157 Pentadecapeptide 50 mg

BPC-157 Pentadecapeptide 50 mg

Manufacturer: Purple Top

Active Substance: BPC-157 (Body Protect Compound)

Pack Size: 10 vials x 5 mg

Total Content: 50 mg

Form: Lyophilized powder (for reconstitution)

This high-purity BPC-157 peptide (Body Protect Compound) is offered by Purple Top in a concentrated, multi-vial pack suitable for extensive laboratory and preclinical studies. Each pack contains 10 vials x 5mg of BPC-157.

BPC-157 is an extremely stable synthetic peptide sequence that is actively researched for its remarkable regenerative and cytoprotective properties.

BPC-157: The Body Protect Compound

BPC-157 is a 15-amino acid sequence that is a fragment of a larger protective protein naturally found in human gastric juices. Its full chemical designation highlights its complexity:

• Long Chemical Name: L-Valine, glycyl-L-alpha-glutamyl-L-prolyl-L-prolyl-L-prolylgsil-L-lysyl-L-prolyl-L-alanyl-L-alpha-aspartyl-L-alpha-aspartyl-L-alanylglisil-L-leucine; glycyl-L-alpha-glutamyl-L-prolyl-L-prolyl-L-prolylglisilsil-L-prolyl-L-alanyl-L-alpha-aspartyl-L-alpha-aspartyl-L-alanylglisil-L-leusil-L-valine.

• Action: When isolated and highly concentrated, the compound exhibits extremely high biological healing activity in various systemic and local applications within research models.

Key Research Findings and Applications

Since 1991, extensive in vitro (test tube) and in vivo (rodent) studies have demonstrated BPC-157’s potential to facilitate repair in numerous tissue types:

1. Musculoskeletal and Connective Tissue Repair

• Tendon & Ligament Healing: Shown to promote tendon growth, cell survival, and cell migration. Studies in rodent models demonstrate accelerated healing of damaged Achilles tendons and medial collateral ligaments.

• Muscle Regeneration: Successfully reversed systemic corticosteroid-damaged muscle healing in rodent models (e.g., crushed gastrocnemius muscles).

• Bone Healing: Promotes accelerated repair in models involving segmental bone defects (demonstrated in rabbits).

• Mechanism: Facilitates healing from tendon to bone junctions.

2. Gastrointestinal (GI) and Cytoprotective Effects

• Inflammatory Bowel Disease (IBD): Repaired damage from IBD in rodent models within days following oral application.

• Anti-Ulcer & Protection: Known as a “stable gastric pentadecapeptide,” it exhibits strong ulcer-preventive effects and eliminates the harmful effects of certain painkillers on the GI tract.

• GI Tract Healing: Causes anabolic healing effects throughout both the upper and lower GI tract.

3. Wound Healing and Angiogenesis

• BPC-157 accelerates general wound healing.

• It interacts with the Nitric Oxide (NO) system to promote the preservation of endothelial tissue and an angiogenic (blood vessel forming) wound healing effect.

Research Dosing Parameters (Anecdotal)

While this product is sold for research purposes only, systematic effectiveness in animal models has been reported with injections in the range of 1-10 micrograms  per kilogram of body weight once a day.

Anecdotal reports among research communities suggest successful total daily doses often range from 200 micrograms to 800 micrograms, with some citing success at 250-350 micrograms twice a day (500-700 micrograms total). Note: There is no common scientific consensus on human dosage, and these figures are for informational context only.

Regulatory and Patent Context

• Non-Patentability: BPC-157, being a natural gastric juice peptide, cannot be patented, which has limited major pharmaceutical development and marketing.

• FDA Status: BPC-157 is not approved by the FDA as a drug for human use.

• WADA/USADA: While some related peptide hormones are banned, BPC-157 is not currently listed as an illegal compound by WADA or USADA.